Loading…

The morning briefing, in your inbox.

Top Cyprus + world stories, summarised. Every day.

Developed by Muflon

BioOrbit CEO Discusses Cancer Treatment Development in Zero Gravity · Cyprus Report

Tech · World

BioOrbit CEO Discusses Cancer Treatment Development in Zero Gravity

1 sourceFirst reported 11 days agoUpdated 11 days ago

AI summary: catch up in 20 seconds

Katie King, co-founder and CEO of BioOrbit, announced the company's milestone in producing protein crystals in zero gravity.
The achievement occurs during a record-breaking mission to the International Space Station (ISS).
BioOrbit's work focuses on developing cancer treatments through the unique conditions of space.
This mission represents the largest scale production of protein crystals conducted in the ISS.
King emphasizes the potential for zero gravity to advance medical research and treatment development.

Generated by AI from the 1 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 1 sources below · always verify with the originals

All coverage (1)

BioOrbit CEO on Developing Cancer Treatments in Zero GravityBloomberg · 11 days ago

No comments yet. Be the first to join the discussion.

AI summary: catch up in 20 seconds

Katie King, co-founder and CEO of BioOrbit, announced the company's milestone in producing protein crystals in zero gravity.
The achievement occurs during a record-breaking mission to the International Space Station (ISS).
BioOrbit's work focuses on developing cancer treatments through the unique conditions of space.
This mission represents the largest scale production of protein crystals conducted in the ISS.
King emphasizes the potential for zero gravity to advance medical research and treatment development.

Generated by AI from the 1 sources below · always verify with the originals